VAXELIS: payments to doctors
Payments that named VAXELIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.5M
- Providers
- 44,690
- Transactions
- 130,318
- Average per transaction
- $19
The per-transaction average — $19 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 44,690 providers the average total is $55, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $1,664,593 | 67.9% |
| Sanofi Pasteur Inc. | $788,360 | 32.1% |